Associate Director, Real-World Evidence & Epidemiology

Natera
$176,000 - $220,000Remote

About The Position

We are seeking a Principal Clinical Scientist / Associate Director of Real-World Evidence & Epidemiology to drive observational evidence strategy for our Early Cancer Detection (ECD) portfolio. Population-scale liquid biopsy screening requires robust real-world evidence demonstrating clinical utility, clinical decision-making impact, and downstream patient outcomes. This ownership role uses real-world datasets to accelerate standard-of-care implementation across oncology diagnostics. Working with a builder mindset, you will partner across Clinical Science, Medical Affairs, Market Access, and Data Science to convert population-scale observational data into actionable clinical implementation strategies.

Requirements

  • Advanced degree (PhD, MPH, MS, PharmD, or equivalent scientific credential) in epidemiology, health outcomes research, biostatistics, or a highly quantitative field
  • 7+ years of experience leading real-world evidence generation, observational clinical research, or HEOR portfolios within the life sciences industry
  • Documented experience executing observational studies across the entire asset lifecycle, from initial protocol drafting through statistical analysis and publication
  • Deep data competency across real-world data sources, including longitudinal medical claims, electronic health records (EHR), and clinical registries

Nice To Haves

  • Direct experience in oncology clinical trials, molecular diagnostics, or early cancer detection programs is preferred

Responsibilities

  • Lead the design, protocol development, and execution of prospective observational studies, registries, and retrospective database assessments across early cancer detection programs
  • Shape post-market evidence generation strategies by isolating critical clinical utility and implementation hurdles that can be resolved via real-world data assets
  • Translate clinical and market requirements into rigorous, practical study designs, specifying target populations, clinical endpoints, and analytic frameworks
  • Systematically identify and mitigate sources of bias, confounding factors, and missing data variance inherent in real-world healthcare datasets
  • Design protocols evaluating clinical utility across diverse populations, ensuring the data generated directly supports precision interventions for individual patients and families
  • Partner across Clinical Science, Medical Affairs, Product Management, and Market Access to prioritize evidence generation initiatives based on regulatory and clinical urgency
  • Collaborate with Biostatistics and Data Science to engineer statistical analysis plans, interpret data findings, and deliver clinical contextualization
  • Extract empirical evidence from early commercial and Laboratory Developed Test (LDT) cohorts to isolate adoption variables, diagnostic compliance, and real-world clinical workflows
  • Deliver real-world data assets that dismantle payer coverage barriers and ground product positioning strictly in clinical utility metrics
  • Convert complex epidemiological findings into clear, high-integrity scientific narratives for internal product governance and external healthcare stakeholders
  • Spearhead the development of peer-reviewed abstracts, posters, presentations, and core manuscripts for major oncology and diagnostic conferences
  • Engage with external clinical collaborators, investigators, and key opinion leaders (KOLs) to advance the platform base for early cancer detection

Benefits

  • comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
  • free testing for employees and their immediate families
  • fertility care benefits
  • pregnancy and baby bonding leave
  • 401k benefits
  • commuter benefits
  • generous employee referral program
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service